510(k) Report

510(k) · Cleared

Cleared

SherpaPak Pediatric Liver Transport System

K201048510(k) TraditionalCleared Jul 2, 202072-day reviewClass II21 CFR 876.5880

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Paragonix Technologies · KDN System, Perfusion, Kidney

Cleared on Jul 2, 2020 after a 72-day review. FDA’s file for it is a 510(k) statement, which names no predicate.

Decided
Jul 2, 2020
Review
72 days
Class
Class II
Product code
KDN
Recalls
None
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K201048Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KDN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KDN device

  1. #1 K261644 Perfadex Plusscore 12.9 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All KDN devices

KDN System, Perfusion, Kidney: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · KDN

5in 2025

2008: 22009: 22010: 12012: 12014: 22015: 12016: 12018: 22019: 22020: 22021: 32022: 12023: 22024: 22025: 52026 (partial year): 3
2007high 5 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KDN

135in 2025

2021: 238 days median2025: 135 days median2026 (partial year): 66 days median
2007high 238 (2021) · low 135 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KDN

1in 2022

2010: 12022: 12026 (partial year): 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KDN

3in 2025

2008: 12016: 32017: 62018: 42019: 32020: 92021: 12025: 3
2007high 9 (2020) · low 0 (2007)2025

MAUDE reports naming product code KDN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20082—01
20092—00
20101—10
20110—00
20121—00
20130—00
20142—00
20151—00
20161—03
20170—06
20182—04
20192—03
20202—09
2021323801
20221—10
20232—00
20242—00
2025513503
20263661—

What is it indicated for?

The Paragonix SherpaPak™ Pediatric Liver Transport System is intended to be used for the static hypothermic preservation of pediatric donor livers or partial adult livers intended for pediatric recipients during transportation and eventual transplantation into a recipient using cold storage solutions indicated for use with the livers. The intended organ storage time for the Paragonix SherpaPak™ Pediatric Liver Transport System is up to 15 hours. Donor…

Read the full statement (100 words)

The Paragonix SherpaPak™ Pediatric Liver Transport System is intended to be used for the static hypothermic preservation of pediatric donor livers or partial adult livers intended for pediatric recipients during transportation and eventual transplantation into a recipient using cold storage solutions indicated for use with the livers. The intended organ storage time for the Paragonix SherpaPak™ Pediatric Liver Transport System is up to 15 hours.

Donor livers exceeding clinically accepted static hypothermic preservation times should be evaluated by the transplant surgeon to determine transplantability in accordance with accepted clinical guidelines and in the best medical interest of the intended recipient.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K201048: SherpaPak Pediatric Liver Transport System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K201048

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026